Impaired efficacy of fenbendazole and ivermectin against intestinal nematodes in adult horses in Iran.

Res Vet Sci

Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, 6517658978 Hamedan, Iran. Electronic address:

Published: January 2024

This study aimed to evaluate the efficacy of fenbendazole and ivermectin on strongyles and Parascaris sp. infecting adult riding horses in three regions with different climates. During 2021 and 2022 fecal specimens were randomly collected from 483 horses older than three years in 31 equestrian clubs in Hamedan (n = 217), Yazd (n = 146) and Tabriz cities (n = 120). Eggs were counted by McMaster technique, and the strongyle larvae were identified using coproculture, PCR and sequencing. Horses with strongyles and Parascaris egg counts ≥150 were enrolled in fecal egg count reduction (FECR) examination following treatment with ivermectin or fenbendazole. In total, 26.5% of examined horses were positive with at least one parasite. Infection rates varied in three cities i.e., 25.8% in Hamedan, 28.8% in Yazd, 25% in Tabriz. Fifty-seven horses had FECR measured. FECR below <90% was observed for IVM-strongyle in two horses in Tabriz, for FBZ-strongyle in two horses in Tabriz and two horses in Hamedan, for IVM-Parascaris in one horse in all three cities, and for FBZ-Parascaris in one horse in Yazd. Furthermore, FECR 90-100% was observed in IVM-Parascaris and FBZ -Parascaris groups in Tabriz. Data herein presented demonstrate different degrees of resistance of strongyles and Parascaris infecting horses in Iran against both ivermectin and fenbendazole. Since non-principled use of anthelminthics is common among horse owners, urgency of test-and-treatment strategy should be educated and implemented by policy-making organizations. Evaluating efficacy of different anthelminthics and choosing the most effective treatment in each region is suggested.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rvsc.2023.105078DOI Listing

Publication Analysis

Top Keywords

efficacy fenbendazole
8
fenbendazole ivermectin
8
strongyles parascaris
8
horses
6
impaired efficacy
4
ivermectin intestinal
4
intestinal nematodes
4
nematodes adult
4
adult horses
4
horses iran
4

Similar Publications

Anthelmintic resistance occurs worldwide in strongyles of ruminants but data from low-income countries are sparse and rarely apply most up to date methods, while effects of management practices in these countries are poorly documented. In Mozambique, benzimidazole resistance has been previously reported; the present study followed this up in detail, applying in vivo faecal egg count (FEC) reduction test (FECRT), in vitro egg hatch test (EHT) and molecular deep amplicon sequencing approaches targeting the internal transcribed spacer 2 (ITS-2, nemabiome) and the isotype 1 β-tubulin gene to determine the resistance status on farms and the strongyle species involved. Adult Landim goats (433) from six semi-intensive and ten extensive farms (22-30 animals/farm) from Maputo Province were visited April 2021 to February 2022.

View Article and Find Full Text PDF

Low intestinal parasite prevalence in Finnish pet dogs and cats.

Acta Vet Scand

September 2024

Department of Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.

Article Synopsis
  • - The study assessed the prevalence of endoparasites in dogs and cats in Finland, finding 3.5% in dogs, 3.6% in pet cats, and a staggering 41.3% in shelter cats, indicating significant disparities between household pets and those in shelters.
  • - Common parasites in dogs included Toxocara canis (0.9%) and strongylid eggs (1.7%), while Toxocara cati (3.3%) was prevalent in pet cats; shelter cats had higher rates of multiple parasites, including T. cati at 34.8%.
  • - The study highlighted that a substantial 31.2% of dogs were dewormed less than once
View Article and Find Full Text PDF

Oral Fenbendazole for Cancer Therapy in Humans and Animals.

Anticancer Res

September 2024

Nimni-Cordoba Tissue Engineering and Drug Discovery Lab, Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, CA, U.S.A.

Fenbendazole is a benzimidazole anthelmintic agent commonly used to treat animal parasitic infections. In humans, other benzimidazoles, such as mebendazole and albendazole, are used as antiparasitic agents. Since fenbendazole is not currently approved by the FDA or EMA, its pharmacokinetics and safety in humans have yet to be well-documented in medical literature.

View Article and Find Full Text PDF

Background: CRISPR-Cas13a is renowned for its precise and potent RNA editing capabilities in cancer therapy. While various material systems have demonstrated efficacy in supporting CRISPR-Cas13a to execute cellular functions in vitro efficiently and specifically, the development of CRISPR-Cas13a-based therapeutic agents for intravesical instillation in bladder cancer (BCa) remains unexplored.

Methods: In this study, we introduce a CRISPR-Cas13a nanoplatform, which effectively inhibits PDL1 expression following intravesical instillation.

View Article and Find Full Text PDF

Occurrence of fenbendazole resistance in Parascaris spp. on breeding farms in Sweden.

Vet Parasitol

October 2024

Swedish University of Agricultural Sciences, Department of Animal Biosciences, Section for Parasitology, Box 7036, Uppsala 750 07, Sweden. Electronic address:

Anthelmintic resistance is an increasing problem in many gastrointestinal parasites of grazing animals. Among these, the equine roundworm, Parascaris spp., has developed wide-spread resistance to macrocyclic lactones over the past decades.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!